Literature DB >> 24824736

Ex vivo correlation of the permeability of metoprolol across human and porcine buccal mucosa.

Emil Meng-Lund1, Eva Marxen1, Anne Marie L Pedersen2, Anette Müllertz1, Birgitte Hyrup3, Rene Holm4, Jette Jacobsen5.   

Abstract

The pH partition theory proposes a correlation between fraction of unionized drug substance and permeability. The aim of this study was to compare the permeability of metoprolol and mannitol in ex vivo human and porcine buccal mucosa models at varying pH to validate whether the porcine permeability model is predictive for human buccal absorption. Human (n = 9-10) and porcine (n = 6-7) buccal mucosa were mounted in a modified Ussing chamber, and the kinetics of metoprolol and mannitol transport was assessed for a period of 5.5 h with the pH values of donor medium set at 7.4, 8.5, and 9.0. In addition, hematoxylin-eosin and Alcian blue-van Gieson were used as tissue stains to evaluate the histology and the presence of acidic polysaccharides (e.g., mucins), respectively. The permeability of metoprolol was decreased in human buccal mucosa by almost twofold when compared with porcine buccal mucosa with a positive correlation (r(2) = 0.96) between the permeability assessed in porcine and human buccal mucosa. There was no change in the degree of either epithelial swelling or desquamation when treating with the pH 9.0 donor medium for 5.5 h. These data suggest that buccal mucosa from pigs can be used to predict human buccal absorption.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  absorption; buccal; in vitro/in vivo correlations; metoprolol; human epithelium; pH; permeability; mucosal delivery; passive diffusion

Mesh:

Substances:

Year:  2014        PMID: 24824736     DOI: 10.1002/jps.24010

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Effect of Permeation Enhancers on the Buccal Permeability of Nicotine: Ex vivo Transport Studies Complemented by MALDI MS Imaging.

Authors:  Eva Marxen; Liang Jin; Jette Jacobsen; Christian Janfelt; Birgitte Hyrup; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2018-02-21       Impact factor: 4.200

2.  Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.

Authors:  Renée McCulloch; Mohammed Sattar; Ellen M Henderson; Majella E Lane; Myra Bluebond-Langner
Journal:  Palliat Med       Date:  2017-06-20       Impact factor: 4.762

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.